Shenzhen CAU Technology Co Ltd

SHE:000004 China Biotechnology
Market Cap
$111.14 Million
CN¥815.46 Million CNY
Market Cap Rank
#19140 Global
#4624 in China
Share Price
CN¥6.16
Change (1 day)
+4.94%
52-Week Range
CN¥5.07 - CN¥13.80
All Time High
CN¥50.60
Categories
Companies in China Biotechnology
About

Shenzhen GuoHua Network Security Technology Co., Ltd. engages in mobile Internet services, emergency security, and smart cities businesses. The company focuses on mobile application security, big data security, Internet of Things security, mobile security consulting, mobile security training, mobile security detection, mobile security reinforcement, mobile security awareness, mobile security mana… Read more

Shenzhen CAU Technology Co Ltd (000004) - Net Assets

Latest net assets as of September 2025: CN¥44.24 Million CNY

Based on the latest financial reports, Shenzhen CAU Technology Co Ltd (000004) has net assets worth CN¥44.24 Million CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥260.55 Million) and total liabilities (CN¥216.30 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥44.24 Million
% of Total Assets 16.98%
Annual Growth Rate 4.62%
5-Year Change -95.0%
10-Year Change -55.35%
Growth Volatility 140.84

Shenzhen CAU Technology Co Ltd - Net Assets Trend (1990–2024)

This chart illustrates how Shenzhen CAU Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Shenzhen CAU Technology Co Ltd (1990–2024)

The table below shows the annual net assets of Shenzhen CAU Technology Co Ltd from 1990 to 2024.

Year Net Assets Change
2024-12-31 CN¥72.91 Million -62.39%
2023-12-31 CN¥193.87 Million -45.00%
2022-12-31 CN¥352.52 Million -62.82%
2021-12-31 CN¥948.24 Million -34.91%
2020-12-31 CN¥1.46 Billion +3.73%
2019-12-31 CN¥1.40 Billion +666.10%
2018-12-31 CN¥183.33 Million -0.42%
2017-12-31 CN¥184.09 Million +3.31%
2016-12-31 CN¥178.20 Million +9.13%
2015-12-31 CN¥163.30 Million +3.76%
2014-12-31 CN¥157.38 Million +8.91%
2013-12-31 CN¥144.51 Million -2.40%
2012-12-31 CN¥148.06 Million +6.97%
2011-12-31 CN¥138.41 Million +7.11%
2010-12-31 CN¥129.22 Million +43.87%
2009-12-31 CN¥89.81 Million +5.31%
2008-12-31 CN¥85.28 Million -12.79%
2007-12-31 CN¥97.79 Million -12.91%
2006-12-31 CN¥112.28 Million +12.35%
2005-12-31 CN¥99.94 Million -18.50%
2004-12-31 CN¥122.63 Million -4.51%
2003-12-31 CN¥128.42 Million +3.55%
2002-12-31 CN¥124.02 Million +3.59%
2001-12-31 CN¥119.72 Million -0.97%
2000-12-31 CN¥120.90 Million +14.59%
1999-12-31 CN¥105.51 Million -2.73%
1998-12-31 CN¥108.47 Million -46.09%
1997-12-31 CN¥201.21 Million +4.97%
1996-12-31 CN¥191.69 Million -51.04%
1995-12-31 CN¥391.53 Million +28.27%
1994-12-31 CN¥305.25 Million +7.48%
1993-12-31 CN¥284.00 Million +234.04%
1992-12-31 CN¥85.02 Million 0.00%
1991-12-31 CN¥85.02 Million +441.47%
1990-12-31 CN¥15.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to Shenzhen CAU Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 131394737500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥132.38 Million 206.72%
Other Comprehensive Income CN¥16.48 Million 25.74%
Other Components CN¥1.23 Billion 1919.35%
Total Equity CN¥64.04 Million 100.00%

Shenzhen CAU Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Shenzhen CAU Technology Co Ltd ranked by their market capitalization.

Company Market Cap
Generalplus Technology Inc
TW:4952
 		$80.67 Million
Fu Chun Shin Machinery Manufacture Co Ltd
TWO:6603
 		$80.72 Million
Spheria Emerging Companies Ltd
AU:SEC
 		$80.72 Million
Société de Services de Participations de Direction et d'Elaboration
BR:SPA
 		$80.73 Million
Devyser Diagnostics AB
ST:DVYSR
 		$80.66 Million
ELECO PLC LS-01
F:5H3
 		$80.63 Million
402490
KQ:402490
 		$80.63 Million
Lavipharm S.A
AT:LAVI
 		$80.56 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shenzhen CAU Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 195,574,037 to 64,038,621, a change of -131,535,416 (-67.3%).
  • Net loss of 131,535,415 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-131.54 Million -205.4%
Other Changes CN¥-1.00 -0.0%
Total Change CN¥- -67.26%

Book Value vs Market Value Analysis

This analysis compares Shenzhen CAU Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 12.73x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 7.11x to 12.73x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1991-12-31 CN¥0.87 CN¥6.16 x
1992-12-31 CN¥0.87 CN¥6.16 x
1993-12-31 CN¥2.77 CN¥6.16 x
1994-12-31 CN¥3.01 CN¥6.16 x
1995-12-31 CN¥2.82 CN¥6.16 x
1996-12-31 CN¥1.65 CN¥6.16 x
1997-12-31 CN¥1.83 CN¥6.16 x
1998-12-31 CN¥0.83 CN¥6.16 x
1999-12-31 CN¥0.80 CN¥6.16 x
2000-12-31 CN¥1.06 CN¥6.16 x
2001-12-31 CN¥1.14 CN¥6.16 x
2002-12-31 CN¥1.16 CN¥6.16 x
2003-12-31 CN¥1.19 CN¥6.16 x
2004-12-31 CN¥1.14 CN¥6.16 x
2005-12-31 CN¥1.01 CN¥6.16 x
2006-12-31 CN¥1.02 CN¥6.16 x
2007-12-31 CN¥0.86 CN¥6.16 x
2008-12-31 CN¥0.73 CN¥6.16 x
2009-12-31 CN¥0.76 CN¥6.16 x
2010-12-31 CN¥0.86 CN¥6.16 x
2011-12-31 CN¥0.90 CN¥6.16 x
2012-12-31 CN¥0.92 CN¥6.16 x
2013-12-31 CN¥0.74 CN¥6.16 x
2014-12-31 CN¥0.96 CN¥6.16 x
2015-12-31 CN¥0.97 CN¥6.16 x
2016-12-31 CN¥1.44 CN¥6.16 x
2017-12-31 CN¥1.54 CN¥6.16 x
2018-12-31 CN¥1.30 CN¥6.16 x
2019-12-31 CN¥16.55 CN¥6.16 x
2020-12-31 CN¥8.83 CN¥6.16 x
2021-12-31 CN¥5.88 CN¥6.16 x
2022-12-31 CN¥2.41 CN¥6.16 x
2023-12-31 CN¥1.48 CN¥6.16 x
2024-12-31 CN¥0.48 CN¥6.16 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shenzhen CAU Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -205.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -133.32%
  • • Asset Turnover: 0.32x
  • • Equity Multiplier: 4.86x
  • Recent ROE (-205.40%) is below the historical average (-16.34%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1991 10.92% 15.97% 0.15x 4.43x CN¥671.62K
1992 31.06% 23.82% 0.29x 4.43x CN¥15.31 Million
1993 17.51% 19.25% 0.27x 3.32x CN¥17.48 Million
1994 11.58% 14.25% 0.23x 3.53x CN¥3.98 Million
1995 -4.72% -1.74% 0.49x 5.54x CN¥-34.90 Million
1996 -71.26% -29.62% 0.51x 4.76x CN¥-112.52 Million
1997 10.23% 4.65% 0.56x 3.93x CN¥354.91K
1998 -113.74% -65.87% 0.30x 5.68x CN¥-86.51 Million
1999 9.79% 5.21% 0.38x 4.99x CN¥-140.96K
2000 24.74% 16.80% 0.26x 5.71x CN¥13.11 Million
2001 11.58% 17.90% 0.28x 2.32x CN¥1.51 Million
2002 5.73% 4.61% 0.46x 2.70x CN¥-4.17 Million
2003 3.85% 3.23% 0.50x 2.37x CN¥-6.16 Million
2004 -4.25% -3.81% 0.50x 2.24x CN¥-13.61 Million
2005 -16.06% -22.12% 0.39x 1.84x CN¥-22.03 Million
2006 0.72% 1.36% 0.22x 2.37x CN¥-8.00 Million
2007 -12.82% -22.91% 0.24x 2.35x CN¥-16.50 Million
2008 -18.18% -25.68% 0.26x 2.74x CN¥-17.24 Million
2009 3.88% 4.11% 0.26x 3.62x CN¥-3.90 Million
2010 16.02% 8.85% 0.71x 2.54x CN¥4.37 Million
2011 3.97% 4.01% 0.38x 2.61x CN¥-4.54 Million
2012 2.59% 2.06% 0.50x 2.49x CN¥-5.74 Million
2013 -1.35% -1.42% 0.30x 3.17x CN¥-8.68 Million
2014 4.74% 4.72% 0.24x 4.21x CN¥-4.23 Million
2015 1.53% 1.04% 0.30x 4.89x CN¥-6.91 Million
2016 32.53% 13.66% 1.29x 1.85x CN¥27.22 Million
2017 6.62% 6.18% 0.52x 2.08x CN¥-4.37 Million
2018 -18.56% -5.53% 1.04x 3.21x CN¥-31.19 Million
2019 -0.26% -3.33% 0.07x 1.08x CN¥-142.58 Million
2020 4.44% 23.04% 0.18x 1.07x CN¥-81.06 Million
2021 -53.66% -176.01% 0.26x 1.17x CN¥-603.34 Million
2022 -169.06% -358.01% 0.29x 1.63x CN¥-631.20 Million
2023 -80.27% -142.66% 0.27x 2.11x CN¥-176.55 Million
2024 -205.40% -133.32% 0.32x 4.86x CN¥-137.94 Million

Industry Comparison

This section compares Shenzhen CAU Technology Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $1,145,453,617
  • Average return on equity (ROE) among peers: 15.28%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shenzhen CAU Technology Co Ltd (000004) CN¥44.24 Million 10.92% 4.89x $80.66 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403) $525.49 Million 14.76% 1.41x $1.02 Billion
Nanhua Bio Medicine Co Ltd (000504) $174.34 Million 36.11% 1.61x $288.51 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518) $642.80 Million -4.58% 0.44x $244.62 Million
Chengzhi Shareholding Co Ltd (000990) $1.69 Billion 3.06% 0.97x $850.04 Million
Hualan Biological EngineeringInc (002007) $1.86 Billion 32.78% 0.08x $2.00 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030) $2.09 Billion 4.42% 0.71x $784.18 Million
Shanghai RAAS Blood Products Co Ltd Class A (002252) $831.21 Million 22.32% 0.12x $3.76 Billion
Baolingbao Biology Co Ltd (002286) $2.04 Billion 5.44% 0.31x $398.99 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) $456.61 Million 23.20% 0.29x $347.95 Million